Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002404307 | SCV002705585 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-09-11 | criteria provided, single submitter | clinical testing | The c.1557delT pathogenic mutation, located in coding exon 10 of the MSH2 gene, results from a deletion of one nucleotide at nucleotide position 1557, causing a translational frameshift with a predicted alternate stop codon (p.F519Lfs*7). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Department of Pathology and Laboratory Medicine, |
RCV000503989 | SCV000592507 | pathogenic | not provided | no assertion criteria provided | clinical testing | This is the type of variant expected to cause the disorder. |